Clinical performance of multiplex high-risk e6 mrna expression in comparison with hpv dna subtypes for the identification of women at risk of cervical cancer.

about

Clinical performance of multiplex high-risk e6 mrna expression in comparison with hpv dna subtypes for the identification of women at risk of cervical cancer.

Item

http://www.wikidata.org/entity/Q41260329

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical performance of multip ...... en at risk of cervical cancer.

@en

type

Item

label

Clinical performance of multip ...... en at risk of cervical cancer.

@en

prefLabel

Clinical performance of multip ...... en at risk of cervical cancer.

@en

P1476

Clinical performance of multip ...... en at risk of cervical cancer.

@en

P2093

Chia-Yen Huang

http://www.w3.org/2001/XMLSchema#string

Chih-Ming Ho

http://www.w3.org/2001/XMLSchema#string

Kui-You Pan

http://www.w3.org/2001/XMLSchema#string

Shwu-Fen Chang

http://www.w3.org/2001/XMLSchema#string

Yu-Li Chen

http://www.w3.org/2001/XMLSchema#string

Yun-Yuan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Papillomaviruses and cancer: from basic studies to clinical application

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions.

Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.

Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test

Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears.

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

P304

1404-1412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.24194

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25940199

http://www.w3.org/2001/XMLSchema#string